IRIS UniCatt

Scatena, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.833
EU - Europa 2.885
AS - Asia 2.416
SA - Sud America 479
Continente sconosciuto - Info sul continente non disponibili 75
AF - Africa 61
OC - Oceania 7
Totale 9.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.702
SG - Singapore 982
CN - Cina 700
DE - Germania 616
RU - Federazione Russa 537
SE - Svezia 370
BR - Brasile 363
UA - Ucraina 321
IT - Italia 196
FR - Francia 191
VN - Vietnam 188
PL - Polonia 155
GB - Regno Unito 127
IE - Irlanda 118
TR - Turchia 106
FI - Finlandia 97
IN - India 93
ID - Indonesia 80
CA - Canada 69
JP - Giappone 56
BD - Bangladesh 41
HK - Hong Kong 35
AR - Argentina 30
ES - Italia 29
IQ - Iraq 25
MX - Messico 24
BE - Belgio 23
NL - Olanda 23
VE - Venezuela 20
CO - Colombia 19
KR - Corea 19
ZA - Sudafrica 16
EC - Ecuador 15
MA - Marocco 14
PK - Pakistan 11
MY - Malesia 10
RO - Romania 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 8
AT - Austria 8
CH - Svizzera 8
CL - Cile 8
CZ - Repubblica Ceca 8
HN - Honduras 7
IL - Israele 7
IR - Iran 7
UY - Uruguay 7
UZ - Uzbekistan 7
KE - Kenya 6
PE - Perù 6
PT - Portogallo 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
AU - Australia 5
BO - Bolivia 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EG - Egitto 5
TW - Taiwan 5
AL - Albania 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
LT - Lituania 4
PH - Filippine 4
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
AO - Angola 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GN - Guinea 1
Totale 9.670
Salva come PNG Salva come JPEG
Città #
Ashburn 524
Singapore 501
Chandler 406
San Jose 301
Jacksonville 163
Warsaw 151
Beijing 126
San Mateo 116
Dublin 113
Nanjing 106
New York 95
Wilmington 84
Los Angeles 72
The Dalles 72
Woodbridge 69
Ann Arbor 68
Houston 67
Jakarta 65
Izmir 62
Lauterbourg 60
Fairfield 58
Hefei 58
Dearborn 57
Ho Chi Minh City 53
Boston 49
Hanoi 46
Council Bluffs 45
Lawrence 45
Seattle 44
Tokyo 44
Redmond 43
Chicago 40
Cattolica 37
São Paulo 37
Moscow 33
Frankfurt am Main 32
Hong Kong 32
Helsinki 28
Bremen 27
Santa Clara 26
Mountain View 25
Shanghai 25
Cambridge 23
Kunming 23
Montreal 23
Redwood City 23
Dallas 22
Boardman 21
Munich 21
Milan 20
Nürnberg 20
Rome 20
Zhengzhou 20
Kent 19
Detroit 18
Nanchang 18
Princeton 18
Hangzhou 17
Shenyang 17
London 16
Brussels 15
Buffalo 15
Hebei 15
Atlanta 14
Brooklyn 14
Guangzhou 14
Philadelphia 14
Phoenix 14
Toronto 14
Lancaster 13
University Park 13
Marseille 12
Orem 12
Pune 12
Jiaxing 11
Seoul 11
Belo Horizonte 10
Changsha 10
Johannesburg 10
Baghdad 9
Dhaka 9
Paris 9
Tianjin 9
Turku 9
Edinburgh 8
Memphis 8
Cardiff 7
Da Nang 7
Düsseldorf 7
Haiphong 7
Lanzhou 7
Manchester 7
Simi Valley 7
Stockholm 7
Tashkent 7
Chengdu 6
Chennai 6
Curitiba 6
Indiana 6
Istanbul 6
Totale 4.861
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL ALTERATIONS IN ADULT AND FETAL HEMOGLOBIN SASSARI ASP-ALPHA-126(H9) -] HIS - THE ROLE OF ALPHA(1)ALPHA(2) CONTACT 615
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing 421
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects 218
CA 19-9: Biochemical and Clinical Aspects 216
Advances in Cancer Biomarkers - From biochemistry to clinic for a critical revision 204
Advances in Cancer Stem Cell Biology 203
Neuron Specific Enolase as a biomarker: biochemical and clinical aspects 197
MITOCHONDRIAL DAMAGE AND METABOLIC COMPENSATORY MECHANISMS INDUCED BY HYPEROXIA IN U-937 CELL LINE. 196
A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line 193
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 3. Discovery of Novel Lead Compounds Through Structure-Based Drug Design and Docking Studies 191
Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer 187
Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. 183
The epithelial–mesenchymal transition in cancer: a potential critical topic for translational proteomic research 181
Prognostic value of the reactive oxygen species in severe sepsis and septic shock patients: a-pilot study 181
Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence 178
Immunological role of IgG subclasses 173
Advances in Mitochondrial Medicine 170
A Critical Approach to Clinical Biochemistry of Chromogranin A 169
A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. 168
Bezafibrate Induces a Mitochondrial Derangement in Human Cell Lines. Intriguing Effects for a Peroxisome Proliferator. 168
An update on pharmacological approaches to neurodegenerative diseases. 166
The Role of CA 125 as Tumor Marker: Biochemical and Clinical Aspects 165
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole C2 and/or C4 Substitutions on Biological Activity 160
Circulating tumour cells and cancer stem cells: A role for proteomics in defining the interrelationships between function,phenotype and differentiation with potential clinical applications. 160
The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. 158
CA 19-9: Biochemical and Clinical Aspects 157
Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy 153
Oxygen transport by Fetal Bovine Hemoglobin 147
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. 145
The proteomics of cancer stem cells. Potential clinical applications for innovative research in oncology 144
Cancer stem cells: the development of new cancer therapeutics 140
CA 19-9: Biochemical and Clinical Aspects 140
Immunological role of IgG subclasses 140
Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. 136
Cancer Stem Cells: An Innovative Therapeutic Approach 136
Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications 134
Advances in Heat Shock Proteomics: Towards a Better Understanding of the Physiology and Pathophysiology of Molecular Chaperones. 133
The role of CA 125 as tumor marker: biochemical and clinical aspects 132
A critical approach to clinical biochemistry of Chromogranin A 132
Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks. 130
Cancer Stem Cells: Proteomic Approaches for New Potential Diagnostic and Prognostic Biomarkers 129
Cancer Biomarkers: A Status Quo 128
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative 122
EFFECTS OF GEMFIBROZIL ON THE OXYGEN-TRANSPORT PROPERTIES OF ERYTHROCYTES 121
Resveratrol treatment induces redox stress in red blood cells: a possible role of caspase 3 in metabolism and anion transport 118
Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation growth inhibition and terminal cell differentiation 117
SEPARATION OF REDUCED AND OXIDIZED GLUTATHIONE BY MICELLAR ELECTROKINETIC CAPILLARY CHROMATOGRAPHY 117
Glycolytic enzyme inhibitors in cancer treatment. 115
Cancer Stem Cells: A Revisitation of the “Anaplasia” Concept. In Advances in Cancer Stem Cell Biology 113
Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates. 108
Cellular respiration and dedifferentiation 104
THE MULTIPLE FUNCTIONS OF HEMOGLOBIN 104
Mitochondrial respiration and differentiation 103
Glycated human hemoglobin (HbA1c): functional characteristics and molecular modeling studies 102
Aroyl-Pyrrolyl Hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetilase inhibition 99
Mitochondria and drugs 98
PHYSIOLOGICAL RELEVANCE OF THE OVERALL DELTA-H OF OXYGEN BINDING TO FETAL HUMAN HEMOGLOBIN 97
The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. 97
Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation 93
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key? 91
Nitroflurbiprofen (NicOx). 91
Cytotoxicity of a new endodontic filling material 86
Aroyl-pyrrolyl hydroxyamides: influence of pyrrole C4-phenylacetyl substitution on histone deacetylase inhibition. 83
Totale 9.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022441 0 0 0 59 32 24 14 91 17 26 73 105
2022/20231.663 154 191 94 169 94 137 29 118 583 26 52 16
2023/2024458 25 142 5 12 19 75 16 22 5 23 63 51
2024/20251.120 34 25 85 35 98 43 33 74 156 138 189 210
2025/20262.750 421 103 171 279 406 189 531 151 202 173 67 57
2026/2027573 100 115 250 108 0 0 0 0 0 0 0 0
Totale 9.756